InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (8 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
8
T+90 hit rate
100%
T+90 mean return
+40.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Ackermann Michael, Director. Insider active across 1 company, notably Tarsus Pharmaceuticals, Inc.. Cumulatively, 11 filings have been logged. Breakdown: 1 buy · 8 sells. Total volume traded: €1.7m. Activity tracked since 15 June 2021. The latest transaction was filed on 5 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Ackermann Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
4,257 sharesCommon StockSEC:0001209191-22-037924:0
100,000 shares@ US$13.5074.9% of flowCommon StockSEC:0001209191-22-027856:0
Canonical exit: 3 Aug 2022 (T+90)
2,442 shares@ US$23.853.0% of flowCommon StockSEC:0001819790-21-000059:0
4,964 shares@ US$27.767.0% of flowCommon StockSEC:0001819790-21-000043:0
1,116 shares@ US$25.561.4% of flowCommon StockSEC:0001819790-21-000039:0
200 shares@ US$25.030.3% of flowCommon StockSEC:0001819790-21-000035:0
5,833 shares@ US$25.2427.3% of flowCommon StockSEC:0001209191-21-054888:0
621 shares@ US$25.1520.8% of flowCommon StockSEC:0001209191-21-051193:0
3,129 shares@ US$25.003.9% of flowCommon StockSEC:0001209191-21-050631:0
1,183 shares@ US$25.001.5% of flowCommon StockSEC:0001209191-21-050177:0
4,257 shares0Common StockSEC:0001209191-21-041701:0
11 of 11 declarations
About Ackermann Michael
Ackermann Michael is Administrateur and a Director of Tarsus Pharmaceuticals, Inc. (XNAS). He has 11 filings in total, and across the 11 sampled filings, transactions run from 2021-06-17 to 2022-06-17, with EUR 1280866 of buys and EUR 428432 of sells; the most frequent transaction nature is Cession.
